Refractory Ovarian Carcinoma (DBCOND0110942)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04019288	AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Batiraxcept Durvalumab	treatment	1 / 2	active_not_recruiting
NCT06483048	MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer	Bendamustine Cyclophosphamide	treatment	1	recruiting
NCT03784677	A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors	Calcium SOR-C13	treatment	1	completed
NCT03907527	Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer	No drug interventions	treatment	1	active_not_recruiting
NCT04840589	Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors	Ipilimumab Nivolumab	treatment	1	recruiting
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	Devimistat Fluorouracil Gemcitabine Hydroxychloroquine Lipoic acid	treatment	2	recruiting
NCT04055649	ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer	Benzalkonium Dordaviprone Paclitaxel	treatment	2	recruiting
NCT03756818	TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors	Mivavotinib Paclitaxel	treatment	1	completed
NCT04753216	Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Irinotecan	treatment	2	completed
NCT03691376	Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Aldesleukin Cancer/testis antigen 1 Mechlorethamine	treatment	1	active_not_recruiting
NCT04213794	Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients	Chloride ion Cisplatin Daunorubicin Doxorubicin Platinum Thiosulfuric acid	treatment	0	active_not_recruiting
NCT06315491	A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer	No drug interventions	treatment	2	recruiting
NCT03026062	Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Durvalumab Tremelimumab	treatment	2	recruiting